Mankind Pharma Limited has announced that it will host an Investor Conference Call on Tuesday, February 3, 2026, at 06:00 PM IST. The call is scheduled to discuss the company's business performance and results for the third quarter (Q3) and the first nine months (9M) of the financial year 2026 (FY26).

The management team that will represent the company includes Mr. Rajeev Juneja (Vice Chairman & Managing Director), Mr. Sheetal Arora (Chief Executive Officer & Whole Time Director), Mr. Arjun Juneja (Chief Operating Officer), Mr. Sudipta Roy (Senior President – Sales & Marketing), Mr. Ashutosh Dhawan (Global Chief Financial Officer), Mr. Prakash Agarwal (President – Strategy), and Mr. Abhishek Agarwal (Head - Investor Relations & AVP - Strategy).

Participants can dial in using the provided universal dial-in numbers for India and international toll-free numbers for countries including the USA, UK, Singapore, and Hong Kong. The company also offers a pre-registration option to streamline the joining process. The announcement was made by Mr. Hitesh Kumar Jain, Company Secretary & Compliance Officer.